- Home
- MEDP vs RNR Comparison
MEDP vs RNR Comparison
Compare MEDP & RNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- RNR
- Stock Information
- Founded
- MEDP 1992
- RNR 1993
- Country
- MEDP United States
- RNR Bermuda
- Employees
- MEDP N/A
- RNR N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- RNR Property-Casualty Insurers
- Sector
- MEDP Health Care
- RNR Finance
- Exchange
- MEDP Nasdaq
- RNR Nasdaq
- Market Cap
- MEDP 11.7B
- RNR 13.5B
- IPO Year
- MEDP 2016
- RNR 1995
- Fundamental
- Price
- MEDP $311.80
- RNR $260.10
- Analyst Decision
- MEDP Buy
- RNR Buy
- Analyst Count
- MEDP 10
- RNR 12
- Target Price
- MEDP $388.44
- RNR $289.50
- AVG Volume (30 Days)
- MEDP 442.3K
- RNR 451.9K
- Earning Date
- MEDP 10-21-2024
- RNR 11-06-2024
- Dividend Yield
- MEDP N/A
- RNR 0.60%
- EPS Growth
- MEDP 33.84
- RNR 127.60
- EPS
- MEDP 11.42
- RNR 69.12
- Revenue
- MEDP $2,070,866,000.00
- RNR $12,657,306,000.00
- Revenue This Year
- MEDP $14.01
- RNR N/A
- Revenue Next Year
- MEDP $5.86
- RNR $2.83
- P/E Ratio
- MEDP $27.19
- RNR $3.76
- Revenue Growth
- MEDP 16.24
- RNR 58.85
- 52 Week Low
- MEDP $268.80
- RNR $188.24
- 52 Week High
- MEDP $459.77
- RNR $300.00
- Technical
- Relative Strength Index (RSI)
- MEDP 40.35
- RNR 43.06
- Support Level
- MEDP $356.36
- RNR $254.72
- Resistance Level
- MEDP $366.98
- RNR $300.00
- Average True Range (ATR)
- MEDP 12.77
- RNR 8.31
- MACD
- MEDP 0.39
- RNR -1.47
- Stochastic Oscillator
- MEDP 17.30
- RNR 11.88
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About RNR RenaissanceRe Holdings Ltd.
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.